Cite
HARVARD Citation
Gaudre, N. et al. (2017). Improved Fetal Hemoglobin With mTOR Inhibitor–Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease. American journal of transplantation. 17 (8), pp. 2212-2214. [Online].